BioAtla, Inc.
BCAB
$1.23
-$0.03-2.38%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.50M | 2.00M | 2.00M | 0.00 | 11.00M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.50M | 2.00M | 2.00M | 0.00 | 11.00M |
| Cost of Revenue | 25.06M | 35.40M | 43.57M | 47.23M | 54.08M |
| Gross Profit | -16.56M | -33.40M | -41.57M | -47.23M | -43.08M |
| SG&A Expenses | 15.07M | 17.10M | 17.73M | 19.07M | 20.69M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 40.13M | 52.50M | 61.31M | 66.29M | 74.78M |
| Operating Income | -31.63M | -50.50M | -59.31M | -66.29M | -63.78M |
| Income Before Tax | -31.45M | -50.62M | -59.61M | -64.71M | -59.52M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -31.45 | -50.62 | -59.61 | -64.71 | -59.52 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -31.45M | -50.62M | -59.61M | -64.71M | -59.52M |
| EBIT | -31.63M | -50.50M | -59.31M | -66.29M | -63.78M |
| EBITDA | -31.43M | -50.19M | -58.93M | -65.71M | -63.02M |
| EPS Basic | -25.56 | -41.83 | -50.76 | -57.57 | -55.09 |
| Normalized Basic EPS | -15.77 | -25.93 | -31.73 | -35.98 | -34.43 |
| EPS Diluted | -25.56 | -41.83 | -50.76 | -57.57 | -55.09 |
| Normalized Diluted EPS | -15.77 | -25.93 | -31.73 | -35.98 | -34.43 |
| Average Basic Shares Outstanding | 5.53M | 5.04M | 4.71M | 4.50M | 4.29M |
| Average Diluted Shares Outstanding | 5.53M | 5.04M | 4.71M | 4.50M | 4.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |